Chantix the anti smoking drug, has been linked to an increased risk of psychiatric and mental health problems including suicides, suicide attempts, aggressive and unusual behavior. The FDA has received many reports involving serious and sometimes fatal injuries linked to Chantix to psychiatric side effects.
Lawsuits have been filed on behalf of individuals who died or suffered severe physical injury as a result of a suicide, suicide attempt or suddent unusual behavior.
Chantix (varenicline) is a prescription drug to help people quit smoking. It works by blocking the receptors commonly stimulated by nicotine.
In February 2008, the FDA issued a statement which said that it is likely that there may be an association between Chantix and serious neuropsychiatric symptoms.
Lawsuits are being evaluated by attorneys on behalf of users who have suffered severe physical injury or death as a result of:
Suicide, Attempted Suicide or Sudden Aggressive Behavior
Legal Analysis: Here a brain chemical altering drug released without adquate testing and warning to consumers.